In summary, the existing literature focuses on these cell activation markers in specific pathologies: NGAL in renal disorders, EDN and ECP mostly in the setting of asthma, and tryptase primarily in relation to anaphylaxis and mastocytosis. This evidence concerns the gene RNASE3 and asthma.